Biovie
Quarterly Financials
| Values in thousands | 2024-03-31 | 2023-12-31 |
|---|---|---|
Revenue | $0 | $0 |
Gross Profit | -57 | -57 |
EBITDA | -7,381 | -7,523 |
EBIT | -7,439 | -7,580 |
Net Income | -8,954 | -8,401 |
Net Change In Cash | 0 | 0 |
Free Cash Flow | -5,851 | -5,909 |
Cash | 30,350 | 20,226 |
Basic Shares | 4,480 | 3,817 |
Annual Financials
| Values in thousands | 2023-06-30 | 2022-06-30 | 2021-06-30 |
|---|---|---|---|
Revenue | $0 | $0 | $0 |
Gross Profit | -266 | -237 | -229 |
EBITDA | -45,688 | -23,684 | -137,802 |
EBIT | -45,955 | -23,921 | -138,032 |
Net Income | -50,255 | -26,084 | -183,847 |
Net Change In Cash | 0 | 0 | 0 |
Cost of Revenue | 14,130 | ||
Free Cash Flow | -40,252 | -18,990 | -10,453 |
Cash | 19,460 | 18,641 | 4,511 |
Basic Shares | 3,248 | 2,466 | 1,240 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-06-30 | -$0.79 |
2024-03-31 | -$0.22 |
2023-12-31 | -$0.22 |
2023-09-30 | -$0.29 |
